T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis.
Immunity
View this publicationImmunity
View this publicationFrontiers in tropical diseases
View this publicationEuropean journal of immunology
View this publicationJournal of affective disorders
View this publicationCancer cell international
View this publicationJournal of cancer research and clinical oncology
View this publicationEuropean stroke journal
View this publicationFrontiers in cardiovascular medicine
View this publicationCells
View this publicationInsights into imaging
View this publication